X4 Pharmaceuticals Inc (XFOR)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current XFOR market cap is 16.32M. The company's latest EPS is USD -6.4695 and P/E is -0.44.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 563k | 560k | 106.43M | 28.81M |
| Operating Income | -37.29M | -33.9M | -34.5M | 69.29M | -9.44M |
| Net Income | -51.77M | 90.83M | -36.7M | -39.82M | 282k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3M | 0 | 0 | 0 | 107.56M |
| Operating Income | -59.87M | -85.11M | -88.08M | -107.52M | -36.4M |
| Net Income | -62.13M | -102.64M | -96.41M | -101.17M | -37.45M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 112.18M | 210.61M | 178.17M | 146.45M | 130.01M |
| Total Liabilities | 111.15M | 116.16M | 118.54M | 124.3M | 107.07M |
| Total Equity | 1.04M | 94.45M | 59.62M | 22.15M | 22.94M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 122.87M | 117.18M | 155.59M | 147.26M | 146.45M |
| Total Liabilities | 50.07M | 52.76M | 81.54M | 96.16M | 124.3M |
| Total Equity | 72.8M | 64.41M | 74.05M | 51.1M | 22.15M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -33.6M | -63.87M | -97.91M | -130.9M | -12.37M |
| Investing | -5.32M | 98.54M | 75.61M | 66.99M | -138k |
| Financing | N/A | 20.16M | 20.16M | 20.29M | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -58.82M | -70.91M | -77.1M | -96.51M | -130.9M |
| Investing | -1.36M | -615k | -103k | -14.88M | 66.99M |
| Financing | 12.39M | 74.25M | 117.23M | 88.52M | 20.29M |
| Market Cap | 16.32M |
| Price to Earnings Ratio | -0.44 |
| Price to Sales Ratio | 0.15 |
| Price to Cash Ratio | 0.29 |
| Price to Book Ratio | 0.74 |
| Dividend Yield | - |
| Shares Outstanding | 5.79M |
| Average Volume (1 week) | 637.39k |
| Average Volume (1 Month) | 317.45k |
| 52 Week Change | -91.38% |
| 52 Week High | 33.90 |
| 52 Week Low | 2.67 |
| Spread (Intraday) | 1.5 (35.71%) |
| Company Name | X4 Pharmaceuticals Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.x4pharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
